Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug combinations
Biotech
Gilead-Arcus' TIGIT gets high response in gastric cancer
Gilead has unveiled preliminary data showing that its Arcus-partnered candidate domvanalimab is effective against gastric cancers.
James Waldron
Nov 7, 2023 9:40am
Faron's latest snapshot suggests antibody has leukemia potential
Jul 19, 2023 8:45am
HaemaLogix's myeloma drug boosts responses in Revlimid combo
Jun 29, 2023 9:10am
GSK gives early look at HIV bNAb's power
Oct 25, 2022 10:00am
New Merck lymphoma data could help patients without options
May 26, 2022 5:00pm
Death in Alpine's Keytruda combo trial triggers clinical hold
Mar 7, 2022 9:18am